pharma · Malaria · Pharmacokinetics · CNSP
CNS Pharmaceuticals
CNS Pharmaceuticals trial registry — 22 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- Houston, TX 77027, US
- Founded
- 2017
- Employees
- 12
- Programs
- 21
- Drugs
- 18
- Patents
- 0
CNS Pharmaceuticals clinical trials
Registry index of 22 ClinicalTrials.gov studies linked to CNS Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.
CNS Pharmaceuticals trial registry — 22 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for CNS Pharmaceuticals.
-
9941 — Phase 2
Clinical update -
Sertraline+Antibiotic (penicillin/azithromycin) — Phase 2
Clinical update -
PRA — Phase 1
Clinical update -
DAB — Phase 1
Clinical update -
(+)-SJ000557733 — Phase 1
Clinical update -
Berubicin hydrochloride, Cecenu® 40 mg Kapsel — Phase 2
Clinical update -
vitamin C — Phase 2
Clinical update -
rTMS (repetitive transcranial magnetic stimulation) — Phase 2
Clinical update